Jan 9, 2015, 14:00 PM by Michael Croft

Jan 9, 2015, 00:00 AM by Michael Croft

NEW YORK, NY, UNITED STATES - Jan 9, 2015 - CAMBRIDGE, MA, and NEW YORK, NY (January 9, 2015) - Biogen Idec (NASDAQ: BIIB) and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches

Jan 8, 2015, 10:00 AM by Michael Croft

Forbes | 2014 saw the highest number of new drug applications approved by FDA since 1996, but John LaMattina argues that the year was even more successful than that.

Jan 8, 2015, 09:00 AM by Michael Croft

New York Times | Researchers yesterday announced a new antibiotic found in dirt. Teixobactin has not been tested in humans, but was extremely effective in animal tests.

Jan 8, 2015, 00:00 AM by Michael Croft

DUBLIN, IRELAND - Jan 8, 2015 - CLIRINX Ltd. announced today that it has launched a new web-based platform for clinical research. The software allows researchers manage their studies and collect medical research data using a sophisticated, web-based system

Jan 7, 2015, 14:30 PM by Michael Croft

Bio-IT World | Novartis today became the first big pharma company to announce a CRISPR program, through a deal with Intellia Therapeutics and Caribou Biosciences that will cover CAR-T therapies and hematopoietic stem cell programs.

Jan 7, 2015, 11:15 AM by Michael Croft

Bio-IT World | The $1,000 genome, CRISPR gene therapies, nanopore sequencing, the fall of 23andMe's health service... we look back at six of our most popular stories of 2014, and reflect on how each has developed since.

Jan 7, 2015, 09:00 AM by Michael Croft

Bio-IT World Roundup | Moderna Therapeutics closed a massive private investment round earlier this week, raising $450 million bringing their total funding to $950 million.

Jan 6, 2015, 13:50 PM by Michael Croft

Forbes | 23andMe has signed a deal with Genentech to sequence the whole genomes of 3,000 Parkinson's patients and relatives in its customer community, sharing both genetic and clinical data with the big biotech.

Jan 6, 2015, 10:00 AM by Michael Croft

Bio-IT World | David Mittelman, co-founder of Arpeggi and GCAT, the Genomics Comparison and Analytic Testing (GCAT) platform, has joined Tute Genomics as CSO.

Jan 6, 2015, 00:00 AM by Michael Croft

COLUMBIA AND BETHESDA, MD - Jan 6, 2015 - Columbia, MD and  Bethesda, MD - January 6, 2015 -  TEMIS, the leading provider of Semantic Content Enrichment solutions for the Enterprise, today announced an extension of their collaboration with the American Society for Cell Biology (ASCB) to further hone the ASCB Science Navigator, a bespoke version of TEMIS Luxid® Navigator - Biopharma Edition, as a tool for biomedical research

Jan 5, 2015, 10:55 AM by Michael Croft

FierceBiotech | Spark Therapeutics, a company with a strong Phase III drug candidate bidding to be the first gene therapy approved for use in the U.S., has filed for an IPO, planning to sell $86 million in public shares.

Jan 5, 2015, 10:30 AM by Michael Croft

Reuters | In advance of a final decision to be handed down January 7, the FDA today revealed that staff reviewers have recommended approval of a biologic made by Novartis that imitates Amgen's off-patent Neupogen.

Jan 2, 2015, 11:20 AM by Michael Croft

Bio-IT World | Looking to open its highly sensitive Simoa instruments to new customers, Quanterix is opening an accelerator in its Massachusetts lab, where users can test out homebrewed assays in search of new biomarker tests that detect proteins at extremely low concentrations.

Jan 2, 2015, 10:00 AM by Michael Croft

Reuters | 2014 was a banner year for drug approvals, Reuters reports. 41 novel medications were approved, the most since the all-time high of 53 approvals in 1996.

Jan 2, 2015, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Jan 2, 2015 - GE Healthcare - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations

Dec 31, 2014, 10:20 AM by Michael Croft

Bio-IT World | Inside the Box | As petascale supercomputing systems grow more accessible, there is now an opportunity for life sciences researchers to run computations on genomic or molecular data that would be impossible with desktops or small clusters — but only if they are willing to adapt their informatics tools to new computing architectures.

Dec 30, 2014, 12:10 PM by Michael Croft

Bio-IT World | News and product releases from around the industry, including a study of attitudes toward newborn genomic testing, and Definiens' latest tissue quantification software.

Dec 30, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA, UNITED STATES - Dec 30, 2014 - TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018

Dec 29, 2014, 11:15 AM by Michael Croft

The Scientist | Adam Marcus and Ivan Oransky, the founders of the Retraction Watch blog, offer their annual list of the year's most prominent, spectacular, or telling retractions in the scientific literature.